YARDLEY, Penn. – June, 22, 2022 – Herspiegel, a leading provider of commercial services to pharmaceutical and biotech industries, announces Jay Jackson, PharmD, MPH, BCMAS has joined the firm as a Partner, heading up the Market Access practice. The reimbursement landscape is increasingly complex as pharma and biotech organizations continue to innovate and develop advanced medicines, biosimilars, cell and gene therapy, and digital therapeutics. The demand for effective strategies and tactical execution continues to grow as our clients navigate the complex and dynamic network of payers, providers, patient support services, and influencers involved in brand access, reimbursement, and ultimately patient utilization.
According to Brent Herspiegel, Founder and President, “We are excited to have Jay join our leadership team. He will expand our strategic advisory and operational expertise to our clients’ market access challenges throughout the product lifecycle. Our market access practice is a foundational element in our commercial solutions, we combine commercial insights with access experience to achieve significant outcomes for our clients.”
Mr. Jackson comes to Herspiegel with 20 years of experience partnering with US and global clients of varying sizes and product portfolios to provide value-driven solutions that improve brand performance and maximize patient access to therapies. His experience spans multiple therapeutic areas, including oncology, cardiovascular, respiratory, autoimmune, infectious disease, central nervous system disorders, and rare diseases. He received his Doctor of Pharmacy degree from the Mercer University Southern School of Pharmacy and a Master of Public Health in Epidemiology from the University of South Florida College of Public Health. He also has postdoctoral training that includes the completion of an Outcomes Research Fellowship and a Board Certification in Medical Affairs.
Citing the constantly evolving and increasingly complex market access landscape, Jay Jackson expressed, “I am excited to join a team that brings insights into barriers that patients encounter, implement strategies that unlock product value while effectively generating evidence and communicating to stakeholders to ensure clients achieve their brand goals.”
Herspiegel’s Market Access Practice specializes in access and evidence generation strategies as well as communication and pull-through tactics across the healthcare ecosystem. We leverage our experience across therapeutic areas, advanced medicines, rare diseases, and digital therapeutics to enable optimal commercial outcomes for our clients.
